A systematic review of regional hyperthermia therapy in bladder cancer

International Journal of Hyperthermia

Volumn 32, Issue 4, 2016, Pages 381-389

  Longo, Thomas A ^a   Gopalakrishna, Ajay ^a   Tsivian, Matvey ^a   Van Noord, Megan ^a   Rasch, Coen R ^b   Inman, Brant A ^a   Geijsen, Elisabeth D ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bladder cancer; chemohyperthermia; radiohyperthermia; regional hyperthermia therapy; urothelial carcinoma

Indexed keywords

BLADDER CANCER; BLADDER SPASM; BURN; CANCER RECURRENCE; CHEMOHYPERTHERMIA; CLINICAL PROTOCOL; CYSTITIS; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; HEMATURIA; HUMAN; HYPERTHERMIA; INTESTINE OBSTRUCTION; META ANALYSIS; METASTASIS FREE SURVIVAL; MUSCLE INVASIVE BLADDER CANCER; NON MUSCLE INVASIVE BLADDER CANCER; OBSERVATIONAL STUDY; PAIN; QUALITY CONTROL; RADIOHYPERTHERMIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REGIONAL HYPERTHERMIA THERAPY; REVIEW; SYSTEMATIC REVIEW; THERMOTHERAPY; URINARY TRACT INFECTION; BLADDER TUMOR; TREATMENT OUTCOME;

HUMANS; HYPERTHERMIA, INDUCED; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84965070486     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2016.1157903     Document Type: Review

References (43)

1. R.L.Siegel, K.D.Miller, A.Jemal Cancer statistics, 2015. CA Cancer J Clin 2015;65:5–29.
2. M.Burger, J.W.Catto, G.Dalbagni, H.B.Grossman, H.Herr, P.Karakiewicz,. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013;63:234–41.
3. S.Cambier, R.J.Sylvester, L.Collette, P.Gontero, M.A.Brausi, G.van Andel,. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance bacillus Calmette–Guerin. Eur Urol 2015.
4. The National Comprehensive Cancer Network. Bladder Cancer, version 2.2015.
5. M.C.Hall, S.S.Chang, G.Dalbagni, R.S.Pruthi, J.D.Seigne, E.C.Skinner,. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007;178:2314–30.
6. M.F.Botteman, C.L.Pashos, A.Redaelli, B.Laskin, R.Hauser The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics 2003;21:1315–30.
7. B.Frey, E.M.Weiss, Y.Rubner, R.Wunderlich, O.J.Ott, R.Sauer,. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia 2012;28:528–42.
8. S.Toraya-Brown, S.Fiering Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia 2014;30:531–9.
9. R.Engelhardt Rational for clinical application of hyperthermia and drugs. Rev Med Chir Soc Med Nat Iasi 1987;91:347–52.
10. O.N.Gofrit, A.Shapiro, D.Pode, A.Sidi, O.Nativ, Z.Leib,. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 2004;63:466–71.
11. K.E.Wallner, M.Banda, G.C.Li Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells. Cancer Res 1987;47:1308–12.
12. A.G.van der Heijden, C.F.Jansen, G.Verhaegh, M.A.O'Donnell, J.A.Schalken, J.A.Witjes The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines. Eur Urol 2004;46:670–4.
13. R.Colombo, A.Salonia, Z.Leib, M.Pavone-Macaluso, D.Engelstein Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU Int 2011;107:912–18.
14. P.Rigatti, A.Lev, R.Colombo Combined intravesical chemotherapy with mitomycin C and local bladder microwave-induced hyperthermia as a preoperative therapy for superficial bladder tumors. A preliminary clinical study. Eur Urol 1991;20:204–10.
15. A.Sousa, B.A.Inman, I.Pineiro, V.Monserrat, A.Perez, V.Aparici,. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer. Int J Hyperthermia 2014;30:166–70.
16. T.R.Oliveira, P.R.Stauffer, C.T.Lee, C.D.Landon, W.Etienne, K.A.Ashcraft,. Magnetic fluid hyperthermia for bladder cancer: A preclinical dosimetry study. Int J Hyperthermia 2013;29:835–44.
17. J.van der Zee, D.Gonzalez Gonzalez, G.C.van Rhoon, J.D.van Dijk, W.L.van Putten, A.A.Hart Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355(9210):1119–25.
18. R.J.Lammers, J.A.Witjes, B.A.Inman, I.Leibovitch, M.Laufer, O.Nativ,. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: A systematic review. Eur Urol 2011;60:81–93.
19. Y.Yuan, K.S.Cheng, O.I.Craciunescu, P.R.Stauffer, P.F.Maccarini, K.Arunachalam,. Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma. Med Phys 2012;39:1170–81.
20. M.Wittlinger, C.M.Rodel, C.Weiss, S.F.Krause, R.Kuhn, R.Fietkau,. Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 2009;93:358–63.
21. B.A.Inman, P.R.Stauffer, O.A.Craciunescu, P.F.Maccarini, M.W.Dewhirst, Z.Vujaskovic A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 2014;30:171–5.
22. Z.Petrovich, B.Emami, D.Kapp, M.D.Sapozink, B.Langholz, J.Oleson,. Regional hyperthermia in patients with recurrent genitourinary cancer. Am J Clin Oncol 1991;14:472–7.
23. M.D.Sapozink, F.A.Gibbs, Jr., M.J.Egger, J.R.Stewart Regional hyperthermia for clinically advanced deep-seated pelvic malignancy. Am J Clin Oncol 1986;9:162–9.
24. T.Juang, P.R.Stauffer, O.A.Craciunescu, P.F.Maccarini, Y.Yuan, S.K.Das,. Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia 2014;30:176–83.
25. J.Crezee, P.M.Van Haaren, H.Westendorp, M.De Greef, H.P.Kok, J.Wiersma,. Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: A preclinical study. Int J Hyperthermia 2009;25:581–92.
26. H.P.Kok, S.Ciampa, R.de Kroon-Oldenhof, E.J.Steggerda-Carvalho, G.van Stam, P.J.Zum Vorde Sive Vording,. Toward online adaptive hyperthermia treatment planning: Correlation between measured and simulated specific absorption rate changes caused by phase steering in patients. Int J Radiat Oncol Biol Phys 2014;90:438–45.
27. E.D.Geijsen, T.M.de Reijke, C.C.Koning, P.J.Zum Vorde Sive Vording, J.J.de la Rosette, C.R.Rasch,. Combining mitomycin C and regional 70 MHz hyperthermia in patients with nonmuscle invasive bladder cancer: A pilot study. J Urol 2015;194:1202–8.
28. R.C.Rietbroek, P.J.Bakker, M.S.Schilthuis, A.J.Postma, P.J.Zum Vorde Sive Vording, D.Gonzalez Gonzalez,. Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer. Int J Radiat Oncol Biol Phys 1996;34:887–93.
29. C.K.Lee, C.W.Song, J.G.Rhee, J.A.Foy, S.H.Levitt Clinical experience using 8 MHz radiofrequency capacitive hyperthermia in combination with radiotherapy: Results of a phase I/II study. Int J Radiat Oncol Biol Phys 1995;32:733–45.
30. M.Hiraoka, S.Jo, K.Akuta, Y.Nishimura, Y.Nagata, M.Takahashi,. Clinical results of radiofrequency capacitive hyperthermia in deep-seated tumors. Gan No Rinsho Jap J Cancer Clin 1986;32:1679–84.
31. D.L.Sackett, W.M.Rosenberg, J.A.Gray, R.B.Haynes, W.S.Richardson Evidence based medicine: What it is and what it isn't. 1996. Clin Orthopaed Rel Res 2007;455:3–5.
32. K.Ueda, H.Sakagami, Y.Masui, T.Okamura Single instillation of hydroxypropylcellulose-doxorubicin as treatment for superficial bladder carcinoma. Cancer Chemother Pharmacol 1994;35:S81–S3.
33. S.Noguchi, Y.Kubota, T.Miura, T.Shuin, M.Hosaka Use of methotrexate, vinblastine, adriamycin, and cisplatin in combination with radiation and hyperthermia as neo-adjuvant therapy for bladder cancer. Cancer Chemother Pharmacol 1992;30:S63–S5.
34. H.Hisazumi, K.Nakajima Eight-MHz RF hyperthermia in urological malignancies. Gan To Kagaku Ryoho Cancer Chemother 1988;15:1382–6.
35. A.Trotti, A.D.Colevas, A.Setser, V.Rusch, D.Jaques, V.Budach,. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176–81.
36. K.Naito, T.Hasegawa, T.Ishida, H.Yamamoto, S.Mihara, K.Komatsu,. A clinical survey of advanced bladder cancer: Treatment of advanced and non-resectable bladder cancer. Hinyokika Kiyo Acta Urol Jap 1991;37:1601–6.
37. S.I.Masunaga, M.Hiraoka, K.Akuta, Y.Nishimura, Y.Nagata, S.Jo,. Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer. Int J Hyperthermia 1994;10:31–40.
38. T.Uchibayashi, H.Yamamoto, K.Kunimi, K.Koshida, K.Nakajima Radiofrequency capacitive hyperthermia combined with irradiation or chemotherapy for patients with invasive bladder cancers. Int Urol Nephrol 1995;27:735–41.
39. Y.Nishimura, M.Hiraoka, S.Jo, K.Akuta, Y.Nagata, S.Masunaga,. Radiofrequency (RF) capacitive hyperthermia combined with radiotherapy in the treatment of abdominal and pelvic deep-seated tumors. Radiother Oncol 1989;16:139–49.
40. T.Ohguri, H.Imada, S.Nomoto, F.Kato, K.Yahara, T.Morioka,. Initial experience of bladder preservation therapy using chemoradiotherapy with regional hyperthermia for muscle-invasive bladder cancer. Thermal Med 2005;21:151–8.
41. S.Ip, J.K.Paulus, E.M.Balk, I.J.Dahabreh, E.E.Avendano, J.Lau Role of Single Group Studies in Agency for Healthcare Research and Quality Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality, 2013.
42. N.Cihoric, A.Tsikkinis, G.van Rhoon, H.Crezee, D.M.Aebersold, S.Bodis,. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperthermia 2015;31:609–14.
43. D.Moher, A.Liberati, J.Tetzlaff, D.G.Altman, PRISMA Group. PLoS Med 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097. Epub 2009 Jul 21.